Here are the 424B prospectus supplements from Flowco Holdings Inc. (FLOC) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow FLOC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FLOC filings page.
Flowco Holdings Inc. is registering 7,800,000 shares of Class A common stock for resale by selling stockholders. The prospectus supplement states a public offering price of $22.00 per share and that Flowco will not receive proceeds from these sales.
Subject to the completion of this offering, Flowco intends to repurchase 10% of the shares sold (approximately 780,000 shares) at the offering price in a proposed Share Repurchase. After the offering and the Share Repurchase Flowco says it will no longer be a “controlled company” under NYSE rules; GEC is expected to own ~33.4% (or ~32.1% if the underwriters fully exercise their option) and GEC and White Deer together ~49.4% (or ~48.1% with full exercise).
Flowco Holdings Inc. filed a preliminary prospectus supplement registering 7,800,000 shares of its Class A common stock for resale by selling stockholders. The company is not selling shares here and will receive no proceeds from these resale transactions. Subject to closing, Flowco intends to repurchase 10% of the shares sold in this offering (an illustrative 780,000 shares) at the price received by the selling stockholders; the Share Repurchase is not a condition to the offering.
The filing notes Flowco completed the acquisition of Valiant Artificial Lift Solutions for approximately $200 million on March 2, 2026, funded via available capacity under its revolving credit facility. After the offering, Flowco will no longer be a NYSE “controlled company”; however, GEC and White Deer will retain substantial voting influence (collectively ~49.0% stated pro forma) and certain director nomination and consent rights.